세계의 근시 및 노안 치료 시장 보고서(2025년)

Myopia and presbyopia treatment encompasses procedures or therapies aimed at rectifying and enhancing vision affected by myopia and presbyopia, both in adults and children. The primary objective revolves around diagnosing underlying conditions, mitigating injury risks, alleviating ocular symptoms, and early detection of these eye conditions.

The main focus of myopia and presbyopia treatment is on two specific eye conditions such as myopia and presbyopia. Myopia involves visual images focusing in front of the retina, resulting in reduced clarity when viewing distant objects. Treatments for myopia cater to both adults and children, encompassing corrective measures, surgical interventions, and pharmaceutical approaches. On the other hand, presbyopia treatment methods comprise prescription lenses, contact lenses, intraocular lenses, and refractive surgeries, specifically targeting presbyopia-related visual impairments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The myopia and presbyopia treatment market research report is one of a series of new reports from The Business Research Company that provides myopia and presbyopia treatment market statistics, including myopia and presbyopia treatment industry global market size, regional shares, competitors with a myopia and presbyopia treatment market share, detailed myopia and presbyopia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the myopia and presbyopia treatment industry. This myopia and presbyopia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The myopia and presbyopia treatment market size has grown strongly in recent years. It will grow from $21.04 billion in 2024 to $22.63 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing prevalence of myopia and presbyopia, awareness and education initiatives, shift in lifestyles and screen time, consumer preference for non-surgical treatments, economic growth and healthcare spending, clinical research and development, accessibility to eyecare services.

The myopia and presbyopia treatment market size is expected to see strong growth in the next few years. It will grow to $31.17 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to emergence of gene therapies for eye disorders, focus on vision correction for lifestyle enhancement, growing adoption of orthokeratology, cultural factors impacting eyecare practices, shift towards preventive eyecare. Major trends in the forecast period include telemedicine for vision care, pharmaceutical interventions, customized contact lenses, myopia control devices, advanced intraocular lenses (IoLS), refractive surgery for presbyopia, and lens implant technologies.

The forecast of 8.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. vision care market by increasing the cost of multifocal intraocular lenses and orthokeratology lenses imported from Switzerland and Japan, thereby reducing refractive correction options and elevating ophthalmology practice costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The projected rise in the geriatric population, specifically individuals aged 65 and above, is anticipated to propel the growth of the myopia and presbyopia treatment market. This demographic segment, due to age-related vulnerabilities and lowered immunity, experiences heightened risks of eye-related ailments, including myopia and presbyopia. Treatments targeting these conditions often involve thorough examination of the visual and microscopic elements of the eye, aiding in the identification and management of various eye-related illnesses prevalent among the elderly. According to the World Health Organization's October 2022 report, by 2030, one in six individuals globally will be 60 or older, and by 2050, the worldwide population aged 60 or above is estimated to reach 2.1 billion, indicating a substantial surge in demand for treatments addressing age-related vision issues.

The escalating incidence of vision impairment is poised to drive growth in the myopia and presbyopia treatment market. Vision impairment, characterized by reduced visual interpretative abilities, poses challenges in perceiving and comprehending the surrounding environment. This trend is anticipated to spur the development of treatments, encouraging heightened awareness, innovation, and investments in the field. Notably, a report from the Centers for Disease Control and Prevention in August 2023 highlights a projected increase in vision impairment cases to 8.96 million by 2050 in the United States. Factors contributing to this rise include the prevalence of chronic diseases like diabetes and an aging population. Moreover, approximately 6.8% of children under 18 in the U.S. have been diagnosed with eye and vision issues, emphasizing the need for effective solutions catering to various age groups experiencing visual challenges.

Technologically advanced solutions are a key trend gaining traction in the myopia and presbyopia treatment market. Major companies are focusing on developing innovative solutions to maintain their competitive edge. For instance, in September 2024, Entod Pharmaceuticals, an India-based manufacturing company, launched PresVu Eye Drops, marking the first eye drop in India specifically formulated for treating presbyopia, a common age-related vision condition that typically affects individuals over 40 years old. Approved by the Drug Controller General of India (DCGI), PresVu is designed to reduce the reliance on reading glasses while providing lubrication to the eyes. These eye drops employ advanced dynamic buffer technology, ensuring consistent efficacy and safety for prolonged use.

Companies in the myopia and presbyopia treatment sector are innovating products, such as myopia-combating sun spectacle lenses, to broaden their customer base and drive revenue growth. Notably, in May 2023, HOYA launched MiYOSMART sun spectacle lenses, designed to mitigate myopia progression in children. These lenses, incorporating DIMS Technology, offer specialized options like MiYOSMART Chameleon and MiYOSMART Sunbird, aiming to slow myopia progression while providing sunlight protection. This technology, developed in collaboration with the Hong Kong Polytechnic University, introduces defocus elements to regulate myopia progression during outdoor activities. The market's emphasis on innovation aligns with emerging evidence supporting outdoor time as a preventive measure against myopia, emphasizing the significance of encouraging outdoor engagements for myopic children.

In January 2024, Eyenovia Inc., a US-based ophthalmic pharmaceutical technology company, acquired the development and commercialization rights for MicroPine from Bausch + Lomb Ireland Limited for an undisclosed amount. The purpose of this acquisition is to accelerate the commercialization of advanced ophthalmic products, specifically aimed at treating pediatric progressive myopia, thus enhancing their late-stage pipeline and addressing a significant unmet medical need in the U.S. and Canada. Bausch + Lomb Ireland Limited is an Ireland-based eye health company involved in the development of MicroPine for myopia treatment.

Major companies operating in the myopia and presbyopia treatment market are ALCON Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, Essilor Ltd., Hagg Striet UK Ltd., Johnson & Johnson Vision Inc., Nidek Corporation, Topcon Corporation, Zimmer Ophthalmic Systems AG, AbbVie Inc., Orasis Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Sydnexis Inc., The Cooper Companies Inc., Staar Surgical Co., Eyenovia Inc., Allergan PLC, Hoya Corporation, Novartis AG, Menicon Co. Ltd., CooperVision Inc., Visioneering Technologies Inc., AcuFocus Inc., Ocular Therapeutix Inc., SightGlass Vision Inc., Presbia PLC, Ophthotech Corporation, OphthaliX Inc., LensGen Inc., Lightico Ltd., RxSight Inc., Perfect Lens LLC

North America was the largest region in the myopia and presbyopia treatment market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia and presbyopia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the myopia and presbyopia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The myopia and presbyopia treatment market includes revenues earned by entities by performing refractive surgery, lens implants, bifocal surgery services and providing eye sight management treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Myopia and Presbyopia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on myopia and presbyopia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for myopia and presbyopia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The myopia and presbyopia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Myopia; Presbyopia
• 2) By Myopia Treatment Type: Corrective; Surgical; Drugs
• 3) By Presbyopia Treatment Type: Prescription Lenses; Contact Lenses; Intraocular Lenses; Refractive Surgery
• Subsegments:
• 1) By Myopia: Eyeglasses And Contact Lenses; Refractive Surgery; Pharmacological Treatments; Orthokeratology
• 2) By Presbyopia: Multifocal Eyeglasses; Bifocal Contact Lenses; Presbyopia-Correcting Surgery; Pharmacological Treatments
• Companies Mentioned: ALCON Inc.; Bausch & Lomb Incorporated; Carl Zeiss AG; Essilor Ltd.; Hagg Striet UK Ltd.; Johnson & Johnson Vision Inc.; Nidek Corporation; Topcon Corporation; Zimmer Ophthalmic Systems AG; AbbVie Inc.; Orasis Pharmaceuticals Ltd.; Regeneron Pharmaceuticals Inc.; Sydnexis Inc.; The Cooper Companies Inc.; Staar Surgical Co.; Eyenovia Inc.; Allergan PLC; Hoya Corporation; Novartis AG; Menicon Co. Ltd.; CooperVision Inc.; Visioneering Technologies Inc.; AcuFocus Inc.; Ocular Therapeutix Inc.; SightGlass Vision Inc.; Presbia PLC; Ophthotech Corporation; OphthaliX Inc.; LensGen Inc.; Lightico Ltd.; RxSight Inc.; Perfect Lens LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Myopia and Presbyopia Treatment Market Characteristics

3. Myopia and Presbyopia Treatment Market Trends And Strategies

4. Myopia and Presbyopia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Myopia and Presbyopia Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Myopia and Presbyopia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Myopia and Presbyopia Treatment Market Growth Rate Analysis
• 5.4. Global Myopia and Presbyopia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Myopia and Presbyopia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Myopia and Presbyopia Treatment Total Addressable Market (TAM)

6. Myopia and Presbyopia Treatment Market Segmentation

• 6.1. Global Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Myopia
• Presbyopia
• 6.2. Global Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corrective
• Surgical
• Drugs
• 6.3. Global Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Lenses
• Contact Lenses
• Intraocular Lenses
• Refractive Surgery
• 6.4. Global Myopia and Presbyopia Treatment Market, Sub-Segmentation Of Myopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Eyeglasses And Contact Lenses
• Refractive Surgery
• Pharmacological Treatments
• Orthokeratology
• 6.5. Global Myopia and Presbyopia Treatment Market, Sub-Segmentation Of Presbyopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multifocal Eyeglasses
• Bifocal Contact Lenses
• Presbyopia-Correcting Surgery
• Pharmacological Treatments

7. Myopia and Presbyopia Treatment Market Regional And Country Analysis

• 7.1. Global Myopia and Presbyopia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Myopia and Presbyopia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Myopia and Presbyopia Treatment Market

• 8.1. Asia-Pacific Myopia and Presbyopia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Myopia and Presbyopia Treatment Market

• 9.1. China Myopia and Presbyopia Treatment Market Overview
• 9.2. China Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Myopia and Presbyopia Treatment Market

• 10.1. India Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Myopia and Presbyopia Treatment Market

• 11.1. Japan Myopia and Presbyopia Treatment Market Overview
• 11.2. Japan Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Myopia and Presbyopia Treatment Market

• 12.1. Australia Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Myopia and Presbyopia Treatment Market

• 13.1. Indonesia Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Myopia and Presbyopia Treatment Market

• 14.1. South Korea Myopia and Presbyopia Treatment Market Overview
• 14.2. South Korea Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Myopia and Presbyopia Treatment Market

• 15.1. Western Europe Myopia and Presbyopia Treatment Market Overview
• 15.2. Western Europe Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Myopia and Presbyopia Treatment Market

• 16.1. UK Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Myopia and Presbyopia Treatment Market

• 17.1. Germany Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Myopia and Presbyopia Treatment Market

• 18.1. France Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Myopia and Presbyopia Treatment Market

• 19.1. Italy Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Myopia and Presbyopia Treatment Market

• 20.1. Spain Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Myopia and Presbyopia Treatment Market

• 21.1. Eastern Europe Myopia and Presbyopia Treatment Market Overview
• 21.2. Eastern Europe Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Myopia and Presbyopia Treatment Market

• 22.1. Russia Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Myopia and Presbyopia Treatment Market

• 23.1. North America Myopia and Presbyopia Treatment Market Overview
• 23.2. North America Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Myopia and Presbyopia Treatment Market

• 24.1. USA Myopia and Presbyopia Treatment Market Overview
• 24.2. USA Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Myopia and Presbyopia Treatment Market

• 25.1. Canada Myopia and Presbyopia Treatment Market Overview
• 25.2. Canada Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Myopia and Presbyopia Treatment Market

• 26.1. South America Myopia and Presbyopia Treatment Market Overview
• 26.2. South America Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Myopia and Presbyopia Treatment Market

• 27.1. Brazil Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Myopia and Presbyopia Treatment Market

• 28.1. Middle East Myopia and Presbyopia Treatment Market Overview
• 28.2. Middle East Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Myopia and Presbyopia Treatment Market

• 29.1. Africa Myopia and Presbyopia Treatment Market Overview
• 29.2. Africa Myopia and Presbyopia Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Myopia and Presbyopia Treatment Market, Segmentation By Myopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Myopia and Presbyopia Treatment Market, Segmentation By Presbyopia Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Myopia and Presbyopia Treatment Market Competitive Landscape And Company Profiles

• 30.1. Myopia and Presbyopia Treatment Market Competitive Landscape
• 30.2. Myopia and Presbyopia Treatment Market Company Profiles
  • 30.2.1. ALCON Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bausch & Lomb Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Carl Zeiss AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Essilor Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hagg Striet UK Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Myopia and Presbyopia Treatment Market Other Major And Innovative Companies

• 31.1. Johnson & Johnson Vision Inc.
• 31.2. Nidek Corporation
• 31.3. Topcon Corporation
• 31.4. Zimmer Ophthalmic Systems AG
• 31.5. AbbVie Inc.
• 31.6. Orasis Pharmaceuticals Ltd.
• 31.7. Regeneron Pharmaceuticals Inc.
• 31.8. Sydnexis Inc.
• 31.9. The Cooper Companies Inc.
• 31.10. Staar Surgical Co.
• 31.11. Eyenovia Inc.
• 31.12. Allergan PLC
• 31.13. Hoya Corporation
• 31.14. Novartis AG
• 31.15. Menicon Co. Ltd.

32. Global Myopia and Presbyopia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Myopia and Presbyopia Treatment Market

34. Recent Developments In The Myopia and Presbyopia Treatment Market

35. Myopia and Presbyopia Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Myopia and Presbyopia Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Myopia and Presbyopia Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Myopia and Presbyopia Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer